Skip to main content
logo
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
146.34
+0.66 (0.45%)
At close: Aug 31, 2026, 4:00 PM EDT
147.00
+0.66 (0.45%)
After-hours: Aug 31, 2026, 7:51 PM EDT

Gilead Sciences Product Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
HIV
21.80B21.20B20.75B20.40B20.20B19.86B19.61B18.85B
HIV Growth
7.93%6.74%5.82%8.23%9.50%8.34%7.90%3.28%
Oncology
3.31B3.29B3.24B3.24B3.27B3.26B3.29B3.21B
Oncology Growth
1.47%0.98%-1.61%0.81%3.19%6.75%12.18%15.46%
Liver Disease
3.31B3.23B3.22B3.09B3.01B3.04B3.02B2.99B
Liver Disease Growth
10.05%6.02%6.45%3.27%1.31%6.92%8.55%7.43%
Other
746.00M787.00M800.00M779.00M796.00M874.00M889.00M906.00M
Other Growth
-6.28%-9.95%-10.01%-14.02%-13.57%-1.13%3.49%-0.44%
Veklury
656.00M754.00M912.00M1.04B1.45B1.55B1.80B2.18B
Veklury Growth
-54.82%-51.20%-49.28%-52.45%-31.67%-28.70%-17.71%-11.52%

Revenue by Type

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
29.82B29.25B28.92B28.55B28.72B28.58B28.61B28.14B
Product Growth
3.84%2.35%1.07%1.44%3.96%4.77%6.22%3.48%
Other
636.00M487.00M527.00M538.00M144.00M158.00M143.00M155.00M
Other Growth
341.67%208.23%268.53%247.10%-20.44%-9.71%-21.43%-19.69%